Statistics

Total Visits

Views
MERIBEL study: Efficacy of eribulin in first line of taxane-resistant patients with HER2 negative metastatic breast cancer45

Select a period of time:

Number of views in the range

Views
MERIBEL study: Efficacy of eribulin in first line of taxane-resistant patients with HER2 negative metastatic breast cancer32

Views

Views
March 202515
April 20252
May 20250
June 20250
July 202515
August 20250
September 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
United States9
Canada2
Bolivia1
Germany1
Spain1
Mexico1
Senegal1
Trinidad and Tobago1
 

Top cities views

Views
Abbotsford1
Carson1
Chaguanas1
Council Bluffs1
Dakar1
DeSoto1
Dover1
Drumbo1
Hamptonville1
La Paz1